KAKEN PHARMACEUTICAL CO., LTD.

4521・Prime Market・Pharmaceuticals

Official website

KAKEN PHARMACEUTICAL CO., LTD.

4521・Prime Market・Pharmaceuticals

Official website

KAKEN PHARMACEUTICAL CO., LTD.4521

Reference Indicators

Market Cap

1,719¥100M

P/E (Forecast)

22.7x

P/B

1.0x

Dividend Yield (Forecast)

4.88%

ROE

1.4%

EV/EBITDA

54.0x

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	76,034	72,984	72,044	94,035	76,871
Cost of Sales	34,458	33,428	33,505	35,502	36,879
Gross Profit	41,575	39,555	38,539	58,532	39,991
SG&A Expenses	24,511	31,556	29,025	37,497	40,891
Operating Income	17,064	7,998	9,513	21,034	-899
Non-operating Income	543	780	543	701	966
Non-operating Expenses	66	51	106	456	273
Ordinary Income	17,542	8,727	9,951	21,279	-206
Extraordinary Income	197	4	14	250	3,511
Extraordinary Losses	3,854	1,914	168	2,094	991
Pre-tax Income	13,885	6,817	9,796	19,435	2,313
Income Taxes	4,336	1,377	1,770	5,490	168
Net Income	9,549	5,440	8,025	13,945	2,144
EBITDA	19,550	10,566	12,266	23,588	2,426
Gross Margin	54.7%	54.2%	53.5%	62.2%	52.0%
Operating Margin	22.4%	11.0%	13.2%	22.4%	-1.2%
ROA	5.8%	3.3%	4.7%	7.3%	1.2%
ROE	7.0%	4.0%	5.7%	9.4%	1.4%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
薬業	74,328	-2,277	-3.1%
不動産事業	2,543	1,377	54.1%
その他	0	0	0.0%